![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, May 31, 2020 4:51:54 PM
Do they have ability at all to manufacture in the EU? Advent is the contract manufacturer for them over there, but all Advent has is in the UK which might be useless post Brexit.
Not at all useless for UK Specials. The UK Specials scheme is not under any threat. UK Specials will continue whatever happens at the end of the Brexit transition year.
Possible outcomes and likelihoods at end of Brexit transition year:-
No deal exit 45%
Fully negotiated exit 5%
Further transition year 45%
Something else I haven't thought of 5%
No deal exit would mean UK leaves EU and no longer comes under EMA.
Drug regulation in UK would revert to MHRA. And so would approval of any Covid vaccine (God help us...)
Fully negotiated exit. Now looking exceedingly unlikely, because the UK Govt couldn't negotiate their way out of a paper bag at the moment. But if it happened, UK would probably retain some sort of associate membership of EMA and some sort of reciprocal arrangement for drug approval whereby both the EMA and the MHRA would retain part responsibility. Though the UK could negotiate to leave the EMA completely. Which wouldn't be very sensible, give the tatters public services will be in, in 7 months time.
Further transition year. Now looking more likely as time passes. Seeing as precious little negotiating has taken place in the first transition year, might as well have another one.
Something else I haven't thought of. Oh yes, I know what it was.
An election is called due to the disastrous mishandling of Covid. Labour call for another referendum on leaving the EU.
In any of these events, there should be no change to UK Specials.
UK Govt is scratching around looking for UK vaccine manufacturing capacity. They just need to locate a facility they can bring on stream quickly (God help us...)
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM